Gerardo C. Glikin

1.2k total citations
53 papers, 954 citations indexed

About

Gerardo C. Glikin is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gerardo C. Glikin has authored 53 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 28 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gerardo C. Glikin's work include Virus-based gene therapy research (28 papers), Veterinary Oncology Research (16 papers) and Immunotherapy and Immune Responses (12 papers). Gerardo C. Glikin is often cited by papers focused on Virus-based gene therapy research (28 papers), Veterinary Oncology Research (16 papers) and Immunotherapy and Immune Responses (12 papers). Gerardo C. Glikin collaborates with scholars based in Argentina, United States and France. Gerardo C. Glikin's co-authors include Liliana M.E. Finocchiaro, Abraham Worcel, Ida Ruberti, Marcela Solange Villaverde, Gabriel L. Fiszman, Héctor N. Torres, Giuseppe Gargiulo, Daniel Blangy, Diego de Mendoza and Daniela Gardiol and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Gerardo C. Glikin

49 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerardo C. Glikin Argentina 16 589 314 176 173 128 53 954
C. Huet France 13 643 1.1× 188 0.6× 70 0.4× 142 0.8× 59 0.5× 24 1.1k
Sheng‐Hao Chao Singapore 19 925 1.6× 144 0.5× 55 0.3× 188 1.1× 66 0.5× 42 1.3k
June V. Harriss United States 14 1.1k 1.8× 201 0.6× 37 0.2× 192 1.1× 40 0.3× 18 1.4k
Kirk Clark United States 10 1.3k 2.2× 237 0.8× 48 0.3× 92 0.5× 31 0.2× 16 1.5k
Masami Nagahama Japan 19 620 1.1× 74 0.2× 29 0.2× 109 0.6× 44 0.3× 42 956
Neelam Sharma United States 17 450 0.8× 58 0.2× 86 0.5× 241 1.4× 106 0.8× 31 824
Claude Sené France 9 618 1.0× 104 0.3× 62 0.4× 212 1.2× 52 0.4× 12 884
Veit Goder Spain 17 1.2k 2.1× 346 1.1× 17 0.1× 119 0.7× 46 0.4× 26 1.7k
Koshi Imami Japan 23 1.1k 1.9× 95 0.3× 30 0.2× 244 1.4× 26 0.2× 59 1.7k
A Nagata Japan 10 858 1.5× 131 0.4× 19 0.1× 59 0.3× 32 0.3× 11 1.1k

Countries citing papers authored by Gerardo C. Glikin

Since Specialization
Citations

This map shows the geographic impact of Gerardo C. Glikin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo C. Glikin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo C. Glikin more than expected).

Fields of papers citing papers by Gerardo C. Glikin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerardo C. Glikin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo C. Glikin. The network helps show where Gerardo C. Glikin may publish in the future.

Co-authorship network of co-authors of Gerardo C. Glikin

This figure shows the co-authorship network connecting the top 25 collaborators of Gerardo C. Glikin. A scholar is included among the top collaborators of Gerardo C. Glikin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerardo C. Glikin. Gerardo C. Glikin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glikin, Gerardo C. & Liliana M.E. Finocchiaro. (2025). Clinical Trials of Cancer Immunogene Therapies in Companion Animals: An Update (2017–2024). Veterinary Sciences. 12(4). 329–329. 1 indexed citations
2.
Finocchiaro, Liliana M.E., et al.. (2021). Therapeutic potential of the cytosine deaminase::uracil phosphoribosyl transferase/5‐fluorocytosine suicide system for canine melanoma. Veterinary and Comparative Oncology. 20(2). 372–380. 1 indexed citations
4.
Finocchiaro, Liliana M.E., et al.. (2019). Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma. Gene Therapy. 26(10-11). 418–431. 12 indexed citations
6.
Glikin, Gerardo C., et al.. (2017). Inhibition of bioenergetic metabolism by the combination of metformin and 2-deoxyglucose highly decreases viability of feline mammary carcinoma cells. Research in Veterinary Science. 114. 461–468. 8 indexed citations
7.
Finocchiaro, Liliana M.E., et al.. (2016). Bortezomib Enhances the Antitumor Effects of Interferon-β Gene Transfer on Melanoma Cells. Anti-Cancer Agents in Medicinal Chemistry. 17(5). 754–761. 6 indexed citations
8.
Villaverde, Marcela Solange, et al.. (2015). Interferon-β gene transfer induces a strong cytotoxic bystander effect on melanoma cells. Biomedicine & Pharmacotherapy. 72. 44–51. 14 indexed citations
9.
Finocchiaro, Liliana M.E., et al.. (2015). Cytokine-Enhanced Vaccine and Interferon-β plus Suicide Gene Therapy as Surgery Adjuvant Treatments for Spontaneous Canine Melanoma. Human Gene Therapy. 26(6). 367–376. 29 indexed citations
10.
Finocchiaro, Liliana M.E., et al.. (2011). Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas. Research in Veterinary Science. 91(2). 230–234. 23 indexed citations
11.
Villaverde, Marcela Solange, et al.. (2009). Suicide gene therapy on spontaneous canine melanoma: correlations between in vivo tumors and their derived multicell spheroids in vitro. Gene Therapy. 17(1). 26–36. 20 indexed citations
12.
Finocchiaro, Liliana M.E., et al.. (2004). Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids. Cancer Gene Therapy. 11(5). 333–345. 15 indexed citations
13.
Fiszman, Gabriel L., et al.. (2002). A laboratory scale device for microencapsulation of genetically engineered cells into alginate beads. Electronic Journal of Biotechnology. 5(3). 279–283. 12 indexed citations
15.
Finocchiaro, Liliana M.E. & Gerardo C. Glikin. (1998). Intracellular melatonin distribution in cultured cell lines. Journal of Pineal Research. 24(1). 22–34. 36 indexed citations
16.
Finocchiaro, Liliana M.E., et al.. (1995). Sensitivity of human peripheral blood mononuclear leukocytes to visible light. Life Sciences. 57(11). 1097–1110. 10 indexed citations
17.
Barañao, J. Lino, et al.. (1991). A DNA topoisomerase I inhibitor blocks the differentiation of rat granulosa cells induced by follicle-stimulating hormone. Biochemical Journal. 277(2). 557–560. 8 indexed citations
18.
Glikin, Gerardo C., Thomas M. Jovin, & D. J. Arndt‐Jovin. (1991). Interactions ofDrosophillaDNA topoisomerase II with left-handed Z-DNA in supercoiled minicircles. Nucleic Acids Research. 19(25). 7139–7144. 23 indexed citations
19.
Glikin, Gerardo C., et al.. (1984). Osmium tetroxide: a new probe for site-specific distortions in supercoiled DNAs. Nucleic Acids Research. 12(3). 1725–1736. 45 indexed citations
20.
Glikin, Gerardo C., et al.. (1981). Protein kinase activities in Neurospora crassa. Archives of Biochemistry and Biophysics. 206(1). 87–92. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026